Medcann Pharma Ltd

Active status, founded 5 years ago, accounts overdue 3 months, 2 employees, revenue range: 0-1m, real address, 2 directors, 2 owners, solo founder, located in London. Operates in the retail, the wholesale, the processing & manufacturing, the pharmacy, the medical / orthopaedic goods stores, the pharma products, the pharma, the vaccines, medicaments, diagnostic substances, biotech etc industries.

Jani Rishi, Dave Nimesh own this company. The list of owners was changed five years ago. It is not exhaustive, as only owners with more than twenty five percent of shares are published.

Jani Rishi, Dave Nimesh are the directors of this company. The list of directors was changed five years ago.

The company was incorporated five years ago on May 10, 2021.

The registration address is NW2 7FS, England, London, Medcann Connect Centre G110-G111 Oxgate House, Oxgate Lane. The address is real address as five companies registered at the address.

No export country data available for this company. (non-official data, calculated by Corpsignals)

No import country data available for this company. (non-official data, calculated by Corpsignals)

No port data available for this company. (non-official data, calculated by Corpsignals)

No transport mode data available for this company. (non-official data, calculated by Corpsignals)

The company operates in the retail, the wholesale, the processing & manufacturing, the pharmacy, the medical / orthopaedic goods stores, the pharma products, the pharma, the vaccines, medicaments, diagnostic substances, biotech etc industries.

It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50. The last reported current assets is £52,819.

CorpSignals sources its data from UK government records including Companies House and HMRC trade data. Data is updated every 24 hours. While we ensure accuracy through automated validation, please refer to original government sources for legal or compliance purposes.